The Hill reports:
The U.S. Food and Drug Administration’s vaccines and related biological products advisory committee on Thursday morning is set to discuss Pfizer’s request for emergency use authorization of its COVID-19 vaccine. The hearing is scheduled to begin at 9AM Eastern.
The non-binding decision from the agency’s Vaccines and Related Biological Products Advisory Committee, an outside group of experts in infectious diseases and vaccines, is the last step before the FDA is likely to give the final OK to distribute the potentially lifesaving doses throughout the United States. While the FDA does not have to follow the advisory committee’s recommendation, the agency often takes its advice.